Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CD-001 in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating CD-001 to assess safety, tolerability, pharmacokinetics, and preliminary efficacy in adults with advanced solid tumors; e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• CD-001 (CD-001)

Snippet

Sponsor: CD (Suzhou) Biopharma Co., Ltd. | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING